header
Local cover image
Local cover image
Image from OpenLibrary

Evaluation of nitazoxanide in combination with pegylated interferon and ribavirin in treatment of patients with chronic HCV genotype 4 / Mahmoud Mohammad Magdy Taha ; Supervised Gamal Eldeen Esmat Gameel , Maissa Elsaid Elraziky , Badawy Elkholy

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Mahmoud Mohammad Magdy Taha , 2012Description: 76P. : charts , facsimiles ; 25cmOther title:
  • تقييم عقار النيتازوكسانيد فى علاج المرضى المصابين بالتهاب الكبد الفيروسى ج المزمن الطور الجينى الرابع مع الإنترفيرون والريبافيرين [Added title page title]
Subject(s): Online resources: Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine Summary: Sustained virologic response (SVR ) rates of 50 % - 60 % have been achieved in patients with chronic hepatitis C (CHC) genotype 4 treated with peginterferon (PEG-IFN) plus ribavirin (RBV) . The safety and efficacy of nitazoxanide (NTZ) plus peginterferon alfa-2a , with ribavirin , were evaluated in a case controlled study at 2 centers in Egypt . This study aims at assessing the safety and efficacy of NTZ in treating Egyptian patients with CHC in combination with PEG-IFN and RBV
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.33.Ph.D.2012.Ma.E (Browse shelf(Opens below)) Not for loan 01010110060146000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.33.Ph.D.2012.Ma.E (Browse shelf(Opens below)) 60146.CD Not for loan 01020110060146000

Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine

Sustained virologic response (SVR ) rates of 50 % - 60 % have been achieved in patients with chronic hepatitis C (CHC) genotype 4 treated with peginterferon (PEG-IFN) plus ribavirin (RBV) . The safety and efficacy of nitazoxanide (NTZ) plus peginterferon alfa-2a , with ribavirin , were evaluated in a case controlled study at 2 centers in Egypt . This study aims at assessing the safety and efficacy of NTZ in treating Egyptian patients with CHC in combination with PEG-IFN and RBV

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer

Local cover image